User profiles for Rawlings Datir
 | Rawlings DatirUniversity College London Verified email at ucl.ac.uk Cited by 5315 |
[HTML][HTML] SARS-CoV-2 B. 1.617. 2 Delta variant replication and immune evasion
The B.1.617.2 (Delta) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
was first identified in the state of Maharashtra in late 2020 and spread throughout India, …
was first identified in the state of Maharashtra in late 2020 and spread throughout India, …
[HTML][HTML] Sensitivity of SARS-CoV-2 B. 1.1. 7 to mRNA vaccine-elicited antibodies
…, A De Marco, IATM Ferreira, B Meng, RP Datir… - Nature, 2021 - nature.com
Transmission of SARS-CoV-2 is uncontrolled in many parts of the world; control is compounded
in some areas by the higher transmission potential of the B.1.1.7 variant 1 , which has …
in some areas by the higher transmission potential of the B.1.1.7 variant 1 , which has …
[HTML][HTML] SARS-CoV-2 evolution during treatment of chronic infection
The spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is
critical for virus infection through the engagement of the human ACE2 protein 1 and is a major …
critical for virus infection through the engagement of the human ACE2 protein 1 and is a major …
[HTML][HTML] Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2
Although two-dose mRNA vaccination provides excellent protection against SARS-CoV-2,
there is little information about vaccine efficacy against variants of concern (VOC) in …
there is little information about vaccine efficacy against variants of concern (VOC) in …
[PDF][PDF] Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B. 1.1. 7
We report severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike ΔH69/V70
in multiple independent lineages, often occurring after acquisition of receptor binding motif …
in multiple independent lineages, often occurring after acquisition of receptor binding motif …
Recurrent emergence and transmission of a SARS-CoV-2 spike deletion H69/V70
SARS-CoV-2 amino acid replacements in the receptor binding domain (RBD) occur
relatively frequently and some have a consequence for immune recognition. Here we report …
relatively frequently and some have a consequence for immune recognition. Here we report …
SARS-CoV-2 B. 1.617 mutations L452R and E484Q are not synergistic for antibody evasion
The SARS-CoV-2 B.1.617 variant emerged in the Indian state of Maharashtra in late 2020.
There have been fears that 2 key mutations seen in the receptor-binding domain, L452R and …
There have been fears that 2 key mutations seen in the receptor-binding domain, L452R and …
[HTML][HTML] Neutralising antibodies in Spike mediated SARS-CoV-2 adaptation
SARS-CoV-2 Spike protein is critical for virus infection via engagement of ACE2, and amino
acid variation in Spike is increasingly appreciated. Given both vaccines and therapeutics …
acid variation in Spike is increasingly appreciated. Given both vaccines and therapeutics …
[HTML][HTML] SARS-CoV-2 B. 1.617. 2 Delta variant replication, sensitivity to neutralising antibodies and vaccine breakthrough
The SARS-CoV-2 B. 1.617. 2 (Delta) variant was first identified in the state of Maharashtra in
late 2020 and spread throughout India, outcompeting pre-existing lineages including B. …
late 2020 and spread throughout India, outcompeting pre-existing lineages including B. …
[HTML][HTML] SARS-CoV-2 B. 1.617 emergence and sensitivity to vaccine-elicited antibodies
The B.1.617 variant emerged in the Indian state of Maharashtra in late 2020 and has spread
throughout India and to at least 40 countries. There have been fears that two key mutations …
throughout India and to at least 40 countries. There have been fears that two key mutations …
